Related references
Note: Only part of the references are listed.A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-beta ligand-receptor binding
Yong Yang et al.
CHEMICAL COMMUNICATIONS (2011)
Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3
Liu-Ya Tang et al.
EMBO JOURNAL (2011)
被撤回的出版物: Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo(Retracted article. See vol.139,pg.2146,2016)
Sanjeev Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Transforming Growth Factor-beta Induces Epithelial to Mesenchymal Transition and Suppresses the Proliferation and Transdifferentiation of Cultured Human Pancreatic Duct Cells
Jeong-Ah Shin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Effects of Flavonoids on Matrix Metalloproteinase-13 Expression of Interleukin-1β-Treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT Signaling Pathways
Hyun Lim et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Pancreatic cancer: understanding and overcoming chemoresistance
Zhiwei Wang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Naringenin reduces lung metastasis in a breast cancer resection model
Lei Qin et al.
PROTEIN & CELL (2011)
Phenolic Compounds as Selective Antineoplasic Agents against Multidrug-resistant Human Cancer Cells
Noelia Duarte et al.
PLANTA MEDICA (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Naringenin: A Potential Immunomodulator for Inhibiting Lung Fibrosis and Metastasis
Gangjun Du et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Effects of Low Dose Quercetin: Cancer Cell-Specific Inhibition of Cell Cycle Progression
Jae-Hoon Jeong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein
Fa Yun Zhang et al.
PHARMACEUTICAL RESEARCH (2009)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma
H. Fakhrai et al.
CANCER GENE THERAPY (2006)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
L Levy et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta 1 in cultured rat hepatic stellate cells
XJ Liu et al.
PHARMACEUTICAL RESEARCH (2006)
A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers
SK Halder et al.
NEOPLASIA (2005)
TGF-ß and the smad signaling pathway suppor transcriptomic reprogramming during epithelial-mesenchymal cell transition
U Valcourt et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions
C Vandewalle et al.
NUCLEIC ACIDS RESEARCH (2005)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma
S Nakajima et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity:: SB-431542
NJ Laping et al.
MOLECULAR PHARMACOLOGY (2002)
Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5)
JF Callahan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
TGF-β-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
V Ellenrieder et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
